πŸ‡ΊπŸ‡Έ FDA
Patent

US 8071766

HSP90 inhibitors

granted A61PA61P1/04A61P11/00

Quick answer

US patent 8071766 (HSP90 inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/04, A61P11/00, A61P11/06, A61P17/00